MONTANOVA CAPITAL, LLC — 13F Holdings & Portfolio

CIK 1569064 · latest 13F-HR filed 2026-08-14

MONTANOVA CAPITAL, LLC manages $5.47B in 13F-reported U.S. long-equity assets across 96 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are SPY (12.97%), MANE (9.37%), ARQT (5.96%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 21 new positions and exited 14; 41 existing positions rose in reported value and 19 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$5.47B

Long-equity book

Holdings
96

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+21 / −14 / ↑41 / ↓19

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q2 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q1 26 → Q2 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

4 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 44.6%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

Name Title / Status Ownership Type

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

MONTANOVA CAPITAL, LLC Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 STATE STR SPDR S&P 500 ETF T Put SPY 78462F103 $709.4M 12.97% 950,000 SH
2 VERADERMICS INC MANE 922967104 $512.5M 9.37% 4,168,970 SH
3 ARCUTIS BIOTHERAPEUTICS INC ARQT 03969K108 $326.1M 5.96% 12,437,000 SH
4 LEGEND BIOTECH CORP LEGN 52490G102 $204.2M 3.73% 7,070,000 SH
5 PALVELLA THERAPEUTICS INC NE PVLA 697947109 $173.5M 3.17% 1,135,406 SH
6 ARRIVENT BIOPHARMA INC AVBP 04272N102 $156.9M 2.87% 4,515,531 SH
7 BENITEC BIOPHARMA INC BNTC 08205P209 $154.5M 2.83% 11,548,351 SH
8 BIOHAVEN LTD BHVN G1110E107 $153.1M 2.80% 10,286,937 SH
9 ADVANCED MICRO DEVICES INC AMD 007903107 $149.4M 2.73% 257,240 SH
10 ARCUS BIOSCIENCES INC RCUS 03969F109 $147.3M 2.69% 4,776,423 SH
11 TAIWAN SEMICONDUCTOR MANUFAC TSM 874039100 $145.5M 2.66% 304,627 SH
12 NVIDIA CORPORATION NVDA 67066G104 $144.2M 2.64% 720,609 SH
13 EYEPOINT INC EYPT 30233G209 $118.6M 2.17% 8,296,375 SH
14 SYSCO CORP SYY 871829107 $118.0M 2.16% 1,411,550 SH
15 GE AEROSPACE GE 369604301 $116.0M 2.12% 310,262 SH
16 IMMATICS N.V IMTX N44445109 $113.4M 2.07% 11,190,129 SH
17 MGM RESORTS INTERNATIONAL MGM 552953101 $111.2M 2.03% 2,325,360 SH
18 META PLATFORMS INC META 30303M102 $99.0M 1.81% 175,807 SH
19 CAPRICOR THERAPEUTICS INC CAPR 14070B309 $98.6M 1.80% 4,092,784 SH
20 KURA ONCOLOGY INC KURA 50127T109 $94.1M 1.72% 8,575,422 SH
21 MONTE ROSA THERAPEUTICS INC GLUE 61225M102 $85.9M 1.57% 3,549,539 SH
22 AVALYN PHARMACEUTICALS INC AVLN 05348Y105 $82.4M 1.51% 2,503,109 SH
23 HOME DEPOT INC HD 437076102 $79.7M 1.46% 226,053 SH
24 HUT 8 CORP HUT 44812J104 $77.3M 1.41% 670,000 SH
25 CAPITAL ONE FINL CORP COF 14040H105 $66.8M 1.22% 333,098 SH
26 VULCAN MATLS CO VMC 929160109 $63.4M 1.16% 214,978 SH
27 FERGUSON ENTERPRISES INC FERG 31488V107 $58.6M 1.07% 246,758 SH
28 ZURA BIO LTD ZURA G9TY5A101 $55.7M 1.02% 9,443,001 SH
29 INFLARX NV IFRX N44821101 $51.4M 0.94% 22,933,910 SH
30 AURA BIOSCIENCES INC AURA 05153U107 $51.2M 0.94% 7,206,217 SH
31 FAETH THERAPEUTICS INC FTH 81728A207 $50.5M 0.92% 2,020,103 SH
32 ADVISORSHARES TR MSOS 00768Y453 $49.5M 0.90% 9,738,524 SH
33 AMAZON COM INC AMZN 023135106 $48.8M 0.89% 204,860 SH
34 REPLIMUNE GROUP INC REPL 76029N106 $48.6M 0.89% 4,389,836 SH
35 AMPHENOL CORP APH 032095101 $47.5M 0.87% 269,300 SH
36 SPOTIFY TECHNOLOGY S A SPOT L8681T102 $46.7M 0.85% 101,800 SH
37 CONTINEUM THERAPEUTICS INC CTNM 21217B100 $46.6M 0.85% 2,841,334 SH
38 APOLLO GLOBAL MGMT INC APO 03769M106 $45.3M 0.83% 383,300 SH
39 BANK OF AMER CORP BAC 060505104 $45.0M 0.82% 789,720 SH
40 ROUNDHILL ETF TRUST DRAM 77926X320 $44.5M 0.81% 603,000 SH
41 CRINETICS PHARMACEUTICALS IN CRNX 22663K107 $44.4M 0.81% 1,186,279 SH
42 CEREBRAS SYSTEMS INC CBRS 15675D103 $38.0M 0.69% 171,900 SH
43 DICKS SPORTING GOODS INC DKS 253393102 $34.3M 0.63% 151,320 SH
44 BROADCOM INC AVGO 11135F101 $31.6M 0.58% 83,600 SH
45 COMPASS THERAPEUTICS INC CMPX 20454B104 $30.9M 0.56% 14,101,159 SH
46 LEXEO THERAPEUTICS INC LXEO 52886X107 $29.7M 0.54% 6,384,200 SH
47 UNITEDHEALTH GROUP INC UNH 91324P102 $26.7M 0.49% 64,130 SH
48 PROKIDNEY CORP PROK 74291D104 $25.2M 0.46% 12,341,266 SH
49 WHITEHAWK THERAPEUTICS INC WHWK 00032Q104 $19.7M 0.36% 4,300,000 SH
50 SPACE EXPLORATION TECHN CORP SPCX 84615Q103 $17.3M 0.32% 101,200 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $5.47B 96 0001172661-26-003727
2026-03-31 2026-05-15 $3.92B 89 0001172661-26-002340
2025-12-31 2026-02-17 $4.88B 93 0001172661-26-001088
2025-09-30 2025-11-14 $3.91B 93 0001172661-25-004838
Filer Information
Address
11 E 26TH STREET
16TH FLOOR
NEW YORK, NY 10010
Phone
(212) 702-5205
Filing Manager
MONTANOVA CAPITAL, LLC
New York, NY
Signatory
Glenn Shepard
Chief Financial Officer